Literature DB >> 27075909

Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Increase Muscle Strength and Function in Frail Elderly Adults in a Randomized Controlled Trial.

Sakiko Abe1, Osamu Ezaki2, Motohisa Suzuki3.   

Abstract

BACKGROUND: Sarcopenia, the loss of skeletal muscle mass, strength, and function, is common in elderly individuals but difficult to treat.
OBJECTIVE: A combination of nutrients was investigated to treat sarcopenia in very frail elderly adults.
METHODS: We enrolled 38 elderly nursing home residents (11 men and 27 women with a mean ± SD age of 86.6 ± 4.8 y) in a 3-mo randomized, controlled, single-blind, parallel group trial. The participants were randomly allocated to 3 groups. The first group received a daily l-leucine (1.2 g) and cholecalciferol (20 μg)-enriched supplement with 6 g medium-chain triglycerides (TGs) (MCTs) (LD + MCT); the second group received the same leucine and cholecalciferol-enriched supplement with 6 g long-chain TGs (LD + LCT); and the third group did not receive any supplements (control). The supplement and oils were taken at dinner, and changes in muscle mass, strength, and function were monitored.
RESULTS: The increase in body weight in the LD + MCT (1.1 ± 1.0 kg) and LD + LCT (0.8 ± 1.1 kg) groups was greater than that in the control group (-0.5 ± 0.9 kg) (P < 0.05). After 3 mo, participants in the LD + MCT group had a 13.1% increase in right-hand grip strength (1.2 ± 1.0 kg, P < 0.01), a 12.5% increase in walking speed (0.078 ± 0.080 m/s, P < 0.05), a 68.2% increase in a 10-s leg open-and-close test performance (2.31 ± 1.68 n/10 s, P < 0.001), and a 28.2% increase in peak expiratory flow (53 ± 59 L/min, P < 0.01). No significant improvements in muscle mass, strength, or function were observed in the LD + LCT or control groups.
CONCLUSION: The combined supplementation of MCTs (6 g), leucine-rich amino acids, and cholecalciferol at dinner may improve muscle strength and function in frail elderly individuals. This trial was registered at the University Hospital Medical Information Network Clinical Trials Registry as UMIN000017567.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  MCT; cholecalciferol; elderly; essential amino acids; frailty; leucine; muscle atrophy; sarcopenia; vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27075909     DOI: 10.3945/jn.115.228965

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

Review 1.  Applications of Medium-Chain Triglycerides in Foods.

Authors:  Shinji Watanabe; Shougo Tsujino
Journal:  Front Nutr       Date:  2022-06-02

2.  Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism.

Authors:  Ying Wang; Zhenzhen Liu; Yi Han; Jiping Xu; Wen Huang; Zhaoshen Li
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

3.  Got Mylk? The Emerging Role of Australian Plant-Based Milk Alternatives as A Cow's Milk Substitute.

Authors:  Yianna Y Zhang; Jaimee Hughes; Sara Grafenauer
Journal:  Nutrients       Date:  2020-04-28       Impact factor: 5.717

Review 4.  Nutrition and Sarcopenia-What Do We Know?

Authors:  Aravinda Ganapathy; Jeri W Nieves
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

Review 5.  Sarcopenia: A Contemporary Health Problem among Older Adult Populations.

Authors:  Sousana K Papadopoulou
Journal:  Nutrients       Date:  2020-05-01       Impact factor: 5.717

6.  Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial.

Authors:  Francisco M Martínez-Arnau; Rosa Fonfría-Vivas; Cristina Buigues; Yolanda Castillo; Pilar Molina; Aldert J Hoogland; Femke van Doesburg; Leo Pruimboom; Julio Fernández-Garrido; Omar Cauli
Journal:  Nutrients       Date:  2020-03-27       Impact factor: 5.717

7.  Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review.

Authors:  Francisco M Martínez-Arnau; Rosa Fonfría-Vivas; Omar Cauli
Journal:  Nutrients       Date:  2019-10-17       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.